Josh Nathan-Kazis, reporter for Barron's joins Cheddar to discuss reports of approval slowdowns in the FDA.
BUSINESS
FDA Slow To Approve Critical Non-COVID-19 Related Drugs
Josh Nathan-Kazis, reporter for Barron's joins Cheddar to discuss reports of approval slowdowns in the FDA.